| Lisa Ann Mastel, LPC | |
|
1720 University Dr S, Fargo, ND 58103-4940 | |
| (701) 461-5308 | |
| (701) 461-5649 |
| Full Name | Lisa Ann Mastel |
|---|---|
| Gender | Female |
| Speciality | Counselor - Professional |
| Location | 1720 University Dr S, Fargo, North Dakota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013934652 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YP2500X | Counselor - Professional | 46510101 (North Dakota) | Primary |
| Entity Name | Inner Light Counseling Services Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740861954 PECOS PAC ID: 4082057500 Enrollment ID: O20240212001632 |
News Archive
The increasing number of minorities diagnosed with cancer has inspired a variety of initiatives at The University of Texas M. D. Anderson Cancer Center focusing on minority health through research, education and community relations.
Human Genome Sciences, Inc. today announced that it has received preliminary written feedback from the U.S. Food and Drug Administration (FDA) regarding the Company's Biologics License Application (BLA) seeking approval in the United States to market 900-mcg ZALBIN™ (albinterferon alfa-2b, known in Europe as JOULFERON®) dosed every two weeks for the treatment of chronic hepatitis C. FDA has expressed concerns regarding the risk benefit assessment of ZALBIN dosed at 900-mcg every two weeks.
SRI International, an independent nonprofit research and development organization, announced today that it has assumed responsibility for further clinical development of the TAS-108 breast cancer program, in cooperation with Taiho Pharmaceuticals Co., Ltd., a leading Japanese pharmaceutical company. Further clinical development will focus on the lead compound's registration for the treatment of tamoxifen and aromatase inhibitor-resistant breast cancers.
Super Bowl XLVIII is only a couple of days away and many families across the country are gearing up for game day celebrations. Because TVs will be such a large part of the festivities this weekend, the doctors in the Comprehensive Children's Injury Center at Cincinnati Children's Hospital Medical Center wanted to discuss the injury risks associated with TVs and share some steps that adults can take to keep kids safe this weekend and throughout the year.
Tosoh Bioscience LLC has announced the availability of the GPC Glossary and Column Selection Guide app, which offers easy access to 200 Gel Permeation Chromatography (GPC) terms and a GPC column selection wizard for precise directions to the ideal GPC columns for polymer molar mass distribution characterization.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lisa Ann Mastel, LPC 1720 University Dr S, Fargo, ND 58103-4940 Ph: (701) 461-5308 | Lisa Ann Mastel, LPC 1720 University Dr S, Fargo, ND 58103-4940 Ph: (701) 461-5308 |
News Archive
The increasing number of minorities diagnosed with cancer has inspired a variety of initiatives at The University of Texas M. D. Anderson Cancer Center focusing on minority health through research, education and community relations.
Human Genome Sciences, Inc. today announced that it has received preliminary written feedback from the U.S. Food and Drug Administration (FDA) regarding the Company's Biologics License Application (BLA) seeking approval in the United States to market 900-mcg ZALBIN™ (albinterferon alfa-2b, known in Europe as JOULFERON®) dosed every two weeks for the treatment of chronic hepatitis C. FDA has expressed concerns regarding the risk benefit assessment of ZALBIN dosed at 900-mcg every two weeks.
SRI International, an independent nonprofit research and development organization, announced today that it has assumed responsibility for further clinical development of the TAS-108 breast cancer program, in cooperation with Taiho Pharmaceuticals Co., Ltd., a leading Japanese pharmaceutical company. Further clinical development will focus on the lead compound's registration for the treatment of tamoxifen and aromatase inhibitor-resistant breast cancers.
Super Bowl XLVIII is only a couple of days away and many families across the country are gearing up for game day celebrations. Because TVs will be such a large part of the festivities this weekend, the doctors in the Comprehensive Children's Injury Center at Cincinnati Children's Hospital Medical Center wanted to discuss the injury risks associated with TVs and share some steps that adults can take to keep kids safe this weekend and throughout the year.
Tosoh Bioscience LLC has announced the availability of the GPC Glossary and Column Selection Guide app, which offers easy access to 200 Gel Permeation Chromatography (GPC) terms and a GPC column selection wizard for precise directions to the ideal GPC columns for polymer molar mass distribution characterization.
› Verified 9 days ago
Rachel A Blumhardt, Counselor Medicare: Medicare Enrolled Practice Location: 2701 12th Ave S, Fargo, ND 58103 Phone: 701-451-4900 Fax: 651-925-0057 | |
Aleece Jung, LAPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 3401 45th St S, Fargo, ND 58104 Phone: 701-356-4384 Fax: 701-356-4383 | |
Mary Beth Stensgard, Counselor Medicare: Not Enrolled in Medicare Practice Location: 3309 Fiechtner Dr S Ste H, Fargo, ND 58103 Phone: 701-261-6539 | |
Kaitlin Doyle, LAPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 2701 12th Ave S, Fargo, ND 58103 Phone: 701-451-4900 Fax: 651-925-0057 | |
Dale A Carrier, LPCC Counselor Medicare: Not Enrolled in Medicare Practice Location: 2624 9th Ave S, Fargo, ND 58103 Phone: 701-298-4500 Fax: 701-298-4400 | |
Dr. Dixie L Lehman, DMIN Counselor Medicare: Not Enrolled in Medicare Practice Location: 1501 17th Ave. S., First Baptist Church, Fargo, ND 58103 Phone: 701-235-6361 Fax: 701-235-6361 |